Skip to content

Evaluation study of the peripheral infusion leakage in infants and children: ivWatch

Detection of extravascular infiltration and leakage of fluids and drugs during peripheral venous catheter placement: Performance evaluation study of auxiliary equipment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062210017
Enrollment
100
Registered
2021-06-22
Start date
2021-06-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post surgical children

Interventions

After surgery in the PCICU of Okayama University Hospital, patients with implanted PVCs will be fitted with ivWatch, and extravascular invasion and leakage of PVCs will be measured by reflected light

Sponsors

Kanazawa Tomoyuki
Lead Sponsor
TERUMO corporation
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Cjildren scheduled to be admitted to the PCICU after surgery at Okayama University Hospital between the Ethics Committee approval and September 30th, 2022, who have an indwelling peripheral venous catheter will be eligible. (2) Children weighing 2.5 kg or more at the time consent is obtained. (3) Children under 4 years of age at the time of obtaining consent (4) Children who have agreed to participate in the study by parents or gardians If the selection criteria are met again within 30 days of obtaining consent for this study, the patient may be re-enrolled without obtaining consent. However, the site of PVC should be different from the first time.

Exclusion criteria

Exclusion criteria: (1) Chidren with skin symptoms (severe dermatitis, burns, epidermolysis bullosa, or urticaria), scar and bruise. (2) Other children who are deemed unsuitable as research subjects by the principal investigator or sub-researcher.

Design outcomes

Primary

MeasureTime frame
Calculate the difference in time between detection by the healthcare worker's usual management method and detection by ivWatch.

Secondary

MeasureTime frame
1) Incidence of extravascular infiltration/leakage when ivWatch is used Calculate the percentage of extravascular invasion/leakage numbers detected by ivWatch among all observed cases. 2) Sensitivity of ivWatch. Calculate the percentage of the number of extravascular infiltrates/leaks detected by ivWatch prior to the healthcare worker's confirmation of the number of extravascular infiltrates/leaks confirmed by the healthcare worker's. Also calculate the percentage of the number of extravascular infiltrates/leaks detected by ivWatch among the number of extravascular infiltrates/leaks confirmed by the healthcare worker's, regardless of before or after. 3) Specificity and accuracy of ivWatch The number of extravascular infiltrates/leaks not identified by the healthcare worker's is assumed to be the actual number of extravascular infiltrates/leaks that did not occur, and the specificity and accuracy of ivWatch is calculated. Specificity is defined as the ratio of the number of extravascular infiltrates/leaks not detected by ivWatch to the number of extravascular infiltrates/leaks not detected by the healthcare worker's, and accuracy is defined as the ratio of the number of extravascular infiltrates/leaks detected by ivWatch to the number of extravascular infiltrates/leaks confirmed by the healthcare worker's. 4) Other additional analysis may be made based on the findings during implementation of ivWatch functionality and usability.

Contacts

Public ContactTomoyuki Kanazawa

Okayama University Hospital

tyskanazawa@gmail.com+81-86-235-7330

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026